Francois Lionnet

Title: The Innovations of Francois Lionnet

Introduction

Francois Lionnet is a notable inventor based in Paris, France. He has made significant contributions to the field of medical research, particularly in the treatment of hemolytic diseases. His innovative approaches have the potential to improve patient outcomes for those suffering from sickle cell disease.

Latest Patents

Francois Lionnet holds a patent for "Methods for treating vaso-occlusive crisis using non-modified annexin V." This invention relates to methods for determining the risk of severe complications in hemolytic diseases. Specifically, it outlines a method for assessing whether a patient with sickle cell disease is at risk for a vaso-occlusive crisis. The process involves determining the level of cell microparticles in a blood sample and analyzing the heme and/or hemoglobin contained in those microparticles. Additionally, the patent describes a method for preventing vaso-occlusive crises by depleting blood-borne microparticles laden with heme and hemoglobin.

Career Highlights

Throughout his career, Francois Lionnet has worked with esteemed organizations such as the Institut National de la Santé et de la Recherche Médicale and Assistance Publique-Hôpitaux de Paris. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Francois Lionnet has collaborated with notable colleagues, including Olivier Blanc-Brude and Pierre-Louis Tharaux. These partnerships have furthered his research and innovation in the medical field.

Conclusion

Francois Lionnet's contributions to medical research, particularly in the treatment of sickle cell disease, highlight his role as an influential inventor. His patented methods offer promising solutions for patients at risk of vaso-occlusive crises.